Moneycontrol
HomeNewsBusinessReal EstateCOVID-19 impact | More people likely to take up larger homes in the periphery with focus on WFH
Trending Topics

COVID-19 impact | More people likely to take up larger homes in the periphery with focus on WFH

Central locations would retain their allure for HNI/C-suite buyers who can afford larger spaces there, the report noted.

June 08, 2020 / 16:58 IST
Story continues below Advertisement

With the rise of work-from-home (WFH), prospective homebuyers will see sense in shifting to city peripheries and take up larger homes at affordable prices and the 'walk-to-work' concept may lose some sheen, according to a report by Anarock.

The previous 'gold standard' of Indian housing - the walk-to-work/short drive to work, by definition only in and around central corporate workplace hubs - may shed some its popularity for the middle class.

Story continues below Advertisement

Central locations would retain their allure for HNI/C-suite buyers who can afford larger spaces there, the report noted.

"Millennials' new-found preference for buying rather than renting homes, are among the most prominent new residential real estate trends of the COVID-19 era. With the rise of the WFH culture, many may now prefer to live in more spacious and cost-effective homes in less central areas. While sufficient supply currently exists in most of the peripheries, this new demand will eventually also dictate fresh supply. Bigger homes, affordable prices and more generous open spaces in the peripheral areas will draw demand from tenants and buyers alike," said Anuj Puri, Chairman,  ANAROCK Property Consultants.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show